181 related articles for article (PubMed ID: 7535736)
41. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
[TBL] [Abstract][Full Text] [Related]
42. Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis.
Mazzanti R; Messerini L; Monsacchi L; Buzzelli G; Zignego AL; Foschi M; Monti M; Laffi G; Morbidelli L; Fantappié O; Bartoloni Saint Omer F; Ziche M
Hepatology; 1997 Jan; 25(1):229-34. PubMed ID: 8985296
[TBL] [Abstract][Full Text] [Related]
43. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
[TBL] [Abstract][Full Text] [Related]
44. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
45. [Superinfection of hepatitis viruses].
Chen Z; Liu X; Li LY
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Oct; 15(5):275-7. PubMed ID: 7532107
[TBL] [Abstract][Full Text] [Related]
46. Immunological aspects of hepatitis B virus infection.
Edgington TS; Chisari FV
Am J Med Sci; 1975; 270(2):212-27. PubMed ID: 799469
[TBL] [Abstract][Full Text] [Related]
47. Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
Chung H; Watanabe T; Kudo M; Chiba T
J Viral Hepat; 2011 Oct; 18(10):e561-7. PubMed ID: 21914077
[TBL] [Abstract][Full Text] [Related]
48. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
[TBL] [Abstract][Full Text] [Related]
49. Characterization of cell mediated immune responses to the hepatitis B core protein in man.
Sylvan SP; Hellström UB; Flehmig B
Clin Exp Immunol; 1987 May; 68(2):233-41. PubMed ID: 3652517
[TBL] [Abstract][Full Text] [Related]
50. Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus.
Rector WG; Govindarajan S; Horsburgh CR; Penley KA; Cohn DL; Judson FN
Am J Gastroenterol; 1988 Mar; 83(3):262-6. PubMed ID: 3344728
[TBL] [Abstract][Full Text] [Related]
51. Cellular immunity to the hepatitis B virion in acute hepatitis type B.
Fattovich G; Alberti A; Crivellaro C; Pontisso P; Noventa F; Realdi G
Clin Exp Immunol; 1983 Sep; 53(3):645-50. PubMed ID: 6616959
[TBL] [Abstract][Full Text] [Related]
52. [Liver cirrhosis and hepatitis viruses].
Sodeyama T; Furuta S
Nihon Rinsho; 1994 Jan; 52(1):27-32. PubMed ID: 8114306
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis B core antigen specific CD4 response in peripheral blood.
Shirai M; Watanabe S; Nishioka M
Jpn J Exp Med; 1990 Jun; 60(3):93-6. PubMed ID: 1976841
[TBL] [Abstract][Full Text] [Related]
54. T lymphocyte activation in chronic hepatitis B infection: interleukin 2 release and its receptor expression.
Lai KN; Leung JC; Tam JS; Leung NW
Am J Gastroenterol; 1989 Dec; 84(12):1532-7. PubMed ID: 2596455
[TBL] [Abstract][Full Text] [Related]
55. Cell-mediated immunity to HBcAg and HBsAg in patients with chronic hepatitis.
Scaroni C; Cancellieri V; Vernace S; Paronetto F
J Clin Lab Immunol; 1981 Jul; 6(1):45-50. PubMed ID: 7265174
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical studies on intrahepatic lymphocyte infiltrates in chronic type B hepatitis, with special emphasis on the activation status of the lymphocytes.
Yang PM; Su IJ; Lai MY; Huang GT; Hsu HC; Chen DS; Sung JL
Am J Gastroenterol; 1988 Sep; 83(9):948-53. PubMed ID: 3137808
[TBL] [Abstract][Full Text] [Related]
57. Cytokines in viral hepatitis.
Koziel MJ
Semin Liver Dis; 1999; 19(2):157-69. PubMed ID: 10422198
[TBL] [Abstract][Full Text] [Related]
58. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy.
Liaw YF; Chien RN; Lin SM; Yeh CT; Tsai SL; Sheen IS; Chu CM
J Interferon Cytokine Res; 1997 Aug; 17(8):449-52. PubMed ID: 9282824
[TBL] [Abstract][Full Text] [Related]
59. Clinical and immunologic studies on blood donors with chronic asymptomatic infection with hepatitis type B virus (HBV).
Cianciara J
Acta Med Pol; 1975; 16(2):111-26. PubMed ID: 1146607
[No Abstract] [Full Text] [Related]
60. Chronic hepatitis C. Analysis of host immune response by immunohistochemistry.
Marrogi AJ; Cheles MK; Gerber MA
Arch Pathol Lab Med; 1995 Mar; 119(3):232-7. PubMed ID: 7534056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
